This penny stock is cashed up, and just got more

💰 Has the market missed something here?                                                                                                                                                                                                                                                                                                                                                                                                                 January 09, 2024 Sponsored by Happy Friday, 360! TWO SWEET INVITES today! 1) Kenny Glick is live again for complimentary training at 10am EST in the [Warlock Room]( 🧌 – come learn about the power of VWAP indicators! 2) Jeff Bishop’s leading an options-selling refresher session today at 2pm EST (complimentary). His 18-year old son will be joining him to learn as he just made his first Tastytrade account this week → [join HERE at 2EST.]( Join Jeff & co at 2EST today! FOCUS LIST🔎 MCRB - Up over 20% in pre after announcing US FDA Fast Track Designation for SER-155 to prevent GI-associated bacterial infections DTIL - Up over 15% after $17.5 million gene editing deal with TGTX SNTG - Up over 90% in pre on no apparent news *sponsored by RadAI This AI Startup Investment is Winning RAD AI has developed technology that transforms the $633B MarTech industry. Its award-winning AI tells brands who their customer is and how to best create content for them. [Investors are taking notice, here’s why:Â]( 1) $27M raised from 6,000+ investors, including VCs, execs at Google and Amazon. Backed by Adobe Fund for Design. 2) Dubbed “essential AI” for brands looking to attract new audiences and boost ROI. 3) 3X revenue growth, clients include Hasbro, Sweetgreen, MGM and more. [Invest Here]( Disclosure: This is a paid advertisement for RAD AI’s Regulation CF offering. Please read the offering circular at [invest.radintel.ai]( *Sponsored content, please see all disclosures below HOTLIST🔥 MCRB - Up over 20% in pre after announcing US FDA Fast Track Designation for SER-155 to prevent GI-associated bacterial infections Seres Therapeutics (MCRB) is a microbiome therapeutics company that develops microbiome therapeutics to treat the modulation of the colonic microbiome. This morning [the company announced an update]( to the commercial launch of VOWWST, with unaudited net sales of approximately $10.4 million for Q4 2023. In addition the company announced US FDA Fast Track Fast Track Designation for SER-155 to prevent GI-associated bacterial infections. The stock traded up over 20% in pre-market in reaction to the news. The $1.92 area was resistance and then acted as support in pre-market so will be an important level to watch. Above it, targets to the upside are $2, $2.08 and then the pre-market high at $2.15. Beyond that, $2.50 and $3 come into play. Below $1.92, there is potential support at $1.85, $1.75, $1.62 and then a gap to fill at $1.56. DTIL - Up over 15% after $17.5 million gene editing deal with TGTX Precision BioSciences (DTIL), a clinical stage gene editing company, develops ex vivo allogeneic chimeric antigen receptor (CAR) T immunotherapies and in vivo therapies for genetic and infectious diseases in the United States. This morning [the company announced]( the completion of a licensing deal with TG Therapeutics (TGTX) for cell therapy Azer=Cel in the treatment of Autoimmune diseases. Under the agreement, DTIL is to receive $17.5 million in upfront and near-term payments with potential for up to $288 million in other development milestone payments The upfront cash and near-term payments expected to extend precision's cash runway into the first half of 2026 The upfront payment of $7.5 million will consist of cash and the purchase of 2,920,816 shares of Precision common stock by TG Therapeutics at a price of $0.77 per share. In addition, according to Finviz.com, DTIL had cash of [$1 per share](based on yesterday’s close. The stock is up over 15% in pre-market after the news. The $0.45 area has acted as support so far in pre-market and should be an important level to watch. Above it, targets to the upside are $0.48, $0.50, $0.54 and $0.60 and then $0.70. Below it, targets to the downside are $0.42 and then a gap fill at $0.3980. SNTG - Up over 90% in pre on no apparent news Sentage Holding (SNTG) provides a range of financial services. The company offers consumer loan repayment and collection management, loan recommendation and prepaid payment network services in China. There has been no apparent new release by the company, although it traded up over 90% in pre-market trade. A similar thing happened on December 29, 2023, when SNTG traded up over 300% on no news. The $4 area has acted as support so far in pre-market and will be an important level to watch. Above it, targets to the upside are $4.50 and then the pre-market high at $4.77. Beyond that $5, $6, $7 and $8 come into play. Below $4, there is potential support at $3.50, $3.20 and then a gap fill at $2.13. MARKET NEWS 📰 💥More GREAT trading resources: [For great training in options basics, start your journey Jeff Williams]( [Get instant access to Jeff Bishop's top trading ideas]( 💡[Get the hottest stock ideas in Bright Ideas]( VOTE ✅ Tiger Woods and Nike have ended their multi decade long partnership [Good stuff, I prefer Adidas]( [That’s a bad deal for both parties]( [What’s that got to do with the Dallas Cowboys?]( Questions or concerns about our products? Email [Support@360wallstreet.io]( © Copyright 2022, RagingBull DISCLAIMER To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at [( FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. *ISSUER-PAID ADVERTISEMENT: This Issuer has previously paid RagingBull.com, LLC (“Raging Bull”) forty seven thousand five hundred dollars to run advertisements enhancing public awareness of the company. Raging Bull is currently invested in this company. RagingBull is currently an Affiliate for RadAI. If you purchase anything through a link in this email other than RagingBull services, you should assume that we have an affiliate relationship with the company providing the product or service that you purchase, and that we will be paid in some way. We recommend that you do your own independent research before purchasing anything. We believe in the companies we form affiliate relationships with, but please don’t spend any money on these products or services unless you believe they will help you achieve your goals. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of https:// ragingbull. com or RagingBull.com LLC are paid in whole or in part by commission based on their sales of Services to subscribers. *Sponsored Content: If you purchase anything through a link in this email other than RagingBull services, you should assume that we have an affiliate relationship with the company providing the product or service that you purchase, and that we will be paid in some way. We recommend that you do your own independent research before purchasing anything. We believe in the companies we form affiliate relationships with, but please don’t spend any money on these products or services unless you believe they will help you achieve your goals. RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with RagingBull. com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull. com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication [tw]( Update your email preferences or unsubscribe [here]( © 2024 360wallstreet 62 Calef Hwy. #233 Lee, NH 03861, United States of America